Can a simple blood test spot sepsis faster? new study aims to find out

NCT ID NCT07655154

Not yet recruiting Diagnosis Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will check if certain blood markers can quickly tell whether a patient has sepsis or another life-threatening condition. Researchers will measure these markers over 24 hours in emergency patients with organ dysfunction. The goal is to improve early diagnosis and guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood biomarkers (preadrenomedullin, calprotectin, IL-6, IL-8, IL-10, MCP-1)
What this could lead to: If successful, this could lead to a faster, more accurate way to diagnose sepsis in the emergency room, potentially saving lives by enabling earlier treatment.
What could go wrong: This is a very small, early-stage study with only 2 participants planned initially. The biomarkers may not prove reliable enough for routine use, and results may not apply to all sepsis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS

Contacts and locations

Locations

Fondazione IRCCS Policlinico San Matteo

Pavia, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.